The selective hydrogenation of phenol and related derivatives to the corresponding cycloketones requires rationally designed catalysts, which have attracted significant attention.
No takes yet. Share an insight, caveat, or question.
Zhong et al. (2014) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: